Belgium· BE-AMP-SAM303396-00

Invega 9 mg

A paliperidone product containing paliperidone, registered in Belgium by Janssen-Cilag International. The same ATC class is registered in 17 of our 19 countries.

ATC N05AX13

Checked against FAMHP / AFMPS (Belgium) on

Informational only — not a medical device.

SOURCE REGISTER · BEFAMHP / AFMPS (Belgium)normalisedInvega 9 mgATCN05AX13REGISTER NO.BE-AMP-SAM303396-00PACKS LISTED8CHECKEDSeptember 26, 2026

Where it is registered

Paliperidone is registered in 17 of 19 countries.

Countries holding a registration under ATC N05AX13 (paliperidone), each read from that country’s own register.

  • This record: Belgium, from FAMHP / AFMPS (Belgium)
  • 10 of them publish a price we can compare per daily dose

Paliperidone · ATC N05AX13

17 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Franceprice
  • Germany
  • Icelandprice
  • Ireland
  • Italyprice
  • Netherlands
  • Norwayprice
  • Polandprice
  • Sweden
  • Switzerlandprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of paliperidone costs, country by country.

Normalised to the WHO defined daily dose (6 mg), the median price runs from $2.75 in Italy to $11.20 in Switzerland — a ×4.1 gap.

  • 2 markets with a comparable price for this class
  • Public list prices, converted to USD at the rate date shown

Paliperidone · price per daily dose (6 mg)

USD · FX 28 Sept 2026

  • CH Switzerland$11.20
  • IT Italy$2.75
Median listed price per WHO defined daily dose, in each market that publishes a price. Open the full comparison

The record

At a glance

FAMHP / AFMPS (Belgium)
Active substance
Paliperidone
Manufacturer
Janssen-Cilag International
Country
Belgium (BE)
ATC code
N05AX13
ATC class
Paliperidone
Defined daily dose
6 mg, O
Reimbursed
Not published by this register
Source register
FAMHP / AFMPS (Belgium)
Last checked
September 26, 2026

Packs & prices · 8

4 priced
  • be_apb
    2487817
    EUR 50.43
  • be_apb
    2487841
    EUR 92.3
  • be_apb
    3833225
    EUR 92.3
  • be_apb
    3763786
    EUR 92.3
  • be_apb
    0791368
  • be_apb
    7722788
  • be_apb
    7725005
  • be_apb
    4197711

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

346 interactions on record for paliperidone.

Graded by severity as the source publishes them — 45 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan

Paliperidone · interactions on record

346 records

  • 45 severe
  • 252 moderate
  • 2 minor
  • 14 info

Most severe, free to view

  • MetoclopramideA03FA01severe
  • CisaprideA03FA02severe
  • DolasetronA04AA04severe
  • PasireotideH01CB05severe

33 more interactions with mechanism and management, from a commercially licensed source.

Sign in to check
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Paliperidone in 18 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All paliperidone products

Authorised across Europe · EMA

The same active substance is authorised in 30 EEA countries. Names it is sold under:

  • Austria · Denepra, Palibon
  • Bulgaria · Егоропал, Палиперидон Тева
  • Cyprus · Paliperidon Tad, Paliperidone Palmitate Stada
  • Czechia · Balení Pro Zahájení Lécby Psylipax, Dvezlarq
  • Germany · Paliperidon 1 A Pharma, Paliperidon Abz
  • Denmark · Dopelir, Egoropal
  • Estonia · Mopetia, Paliperidone Sandoz
  • Spain · Baceq, Dvezlarq
  • Finland · Lodixeon, Paliperidon Ratiopharm
  • France · Paliperidone Bgr, Paliperidone Biogaran
  • United Kingdom (Northern Ireland) · Paliperidone Mylan, Paliperidone Neuraxpharm Uk
  • Greece · Dopelir, Paliperidone Palmitate Stada
  • Croatia · Arion, Dvezlarq
  • Hungary · Egoropal, Paliperidon Actavis
  • Ireland · Paliperidone Clonmel, Paliperidone Krka
  • Iceland · Byannli, Invega
  • Italy · Palbran, Paliperidone Eg
  • Liechtenstein · Byannli, Invega
  • Lithuania · Paliperidone Sandoz, Paliperidone Teva
  • Luxembourg · Paliperidon Ratiopharm, Paliperidone Eg
  • Latvia · Mopetia, Paliperidone Sandoz
  • Malta · Paliperidone Clonmel
  • Netherlands · Paliperidon Cf, Paliperidon Krka
  • Norway · Byannli, Invega
  • Poland · Dvezlarq, Egoropal
  • Portugal · Aldesven, Fredexel
  • Romania · Mopetia, Paliperidonă Stada
  • Sweden · Denepra, Mopetia
  • Slovenia · Paliperidon Teva, Paliperidon Vale
  • Slovakia · Egoropal, Paliperidón Stada

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FAMHP / AFMPS (Belgium). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/b8b0e5d7-3014-4934-8e9f-5054312c5ebd
GET /v1/drugs/b8b0e5d7-3014-4934-8e9f-5054312c5ebd?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Prolonged-release tablet",
  "source": "afmps",
  "status": "AUTHORIZED",
  "name_en": "Invega 9 mg",
  "name_fr": "Invega 9 mg",
  "name_nl": "Invega 9 mg",
  "amp_code": "SAM303396-00",
  "strengths": [
    "9.0000",
    "9.0000"
  ],
  "pack_count": 23,
  "substances": [
    "Paliperidone",
    "Butylhydroxytoluene",
    "Propylene Glycol",
    "Sodium Chloride"
  ],
  "medicine_type": "ALLOPATHIC",
  "atc_description": "Paliperidone",
  "authorisation_numbers": [
    "EU/1/07/395/011",
    "EU/1/07/395/012",
    "EU/1/07/395/013",
    "EU/1/07/395/014",
    "EU/1/07/395/015",
    "EU/1/07/395/031",
    "EU/1/07/395/032",
    "EU/1/07/395/033",
    "EU/1/07/395/034",
    "EU/1/07/395/035",
    "EU/1/07/395/049",
    "EU/1/07/395/050",
    "EU/1/07/395/051",
    "EU/1/07/395/052",
    "EU/1/07/395/061",
    "EU/1/07/395/062",
    "EU/1/07/395/072",
    "EU/1/07/395/071",
    "EU/1/07/395/073"
  ]
}

See everything about paliperidone.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.